Skip to main content
Research

Publications: DR Prerana Huddar

Huddar P, Graham K, Hubner R, Valle J, McNamara M ( 2023 ) . P-285 Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers – an emerging entity . Annals of Oncology vol. 34 ,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al. ( 2023 ) . Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis . Frontiers in Oncology vol. 13 ,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al. ( 2023 ) . 76 Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis . Lung Cancer vol. 178 ,
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, Cortellini A, Addeo A et al. ( 2023 ) . The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study . International Journal of Molecular Sciences vol. 24 , ( 2 )
Wysocki O, Zhou C, Rogado J, Huddar P, Shotton R, Tivey A, Albiges L, Angelakas A et al. ( 2022 ) . An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves . Cancers vol. 14 , ( 16 )
Lee RJ, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, Woodcock J, Albiges L et al. ( 2022 ) . Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital . JCO Clinical Cancer Informatics vol. 6 , ( 6 )
Huddar P, Califano R ( 2021 ) . Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibition as Maintenance Treatment for SCLC: The Search Must Continue . Journal of Thoracic Oncology vol. 16 , ( 8 ) 1236 - 1238 .
Tivey A, Huddar P, Shotton R, Cheese I, Daniels S, Lorigan P, Lee RJ ( 2021 ) . Patient engagement in melanoma research: from bench to bedside . Future Oncology vol. 17 , ( 28 ) 3705 - 3716 .
Lee R, Wysocki O, Zhou C, Calles A, Eastlake L, Ganatra S, Harrison M, Horsley L et al. ( 2021 ) . CORONET; COVID-19 in Oncology evaluatiON Tool: Use of machine learning to inform management of COVID-19 in patients with cancer . Journal of Clinical Oncology vol. 39 , ( 15_suppl ) 1505 - 1505 .
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K et al. ( 2021 ) . Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’ [ESMO Open Volume 6, Issue 1, February 2021, 100005] . ESMO Open vol. 6 , ( 2 )
Lee R, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L, Woodcock J, Angelakas A et al. ( 2021 ) . Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital .
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K et al. ( 2020 ) . Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome . ESMO Open vol. 6 , ( 1 )
Lee R, Zhou C, Shotton R, Tivey A, Dickens E, Huddar P, McKenzie H, Boyce H et al. ( 2020 ) . Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19 . Annals of Oncology vol. 31 ,
Goode EF, Crawley D, Moss C, Okines A, Archer C, Gale J, Zaidi M, Howells JR et al. ( 2020 ) . UK experience of the management of pregnancy associated breast cancer: A national retrospective review of practice . Annals of Oncology vol. 31 ,
Lee RJ, Zhou C, Wysocki O, Shotton R, Tivey A, Lever L, Woodcock J, Angelakas A et al. . Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital .
Tivey A, Shotton R, Taylor S, Oakley R, Summerton S, Huddar P, King M, Gibson J et al. . Remote monitoring of cancer patients with suspected Covid-19 using wearable sensors and regular mobile data networks; results of the RECAP feasibility study (NCT04397705) .